Savara to present IMPALA-2 trial data at ERS Congress in Barcelona
Tweet Send to a Friend
Savara Inc. (Nasdaq: SVRA) announced that one oral presentation and two poster presentations on data from its Phase 3 IMPALA-2 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


